Personality-Targeted Interventions for Addressing Polysubstance Use among Opioid-Addicted Clients Undergoing Opioid Substitution Therapy: A Feasibility Study

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:3 publications

Grant number: 202010PJK

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $818,779.5
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    N/A

  • Research Location

    Canada
  • Lead Research Institution

    Dalhousie University
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Drug users

  • Occupations of Interest

    Unspecified

Abstract

We are amid a severe opioid crisis, worsened by the COVID-19 pandemic. In Canada, prescription opioid use and opioid overdoses/mortality were soaring pre-pandemic, reaching epidemic levels, with opioid-related deaths only increasing since the pandemic. Powerful and dangerous synthetic opioids (e.g., Fentanyl) are increasingly being used to cut street drugs given disruptions to the drug supply chain with pandemic border closures. More effective interventions for addressing opioid use disorder are sorely needed. An effective mainstay treatment for opioid use disorder in Canada is opioid substitution therapy (OST; e.g., methadone, buprenorphine). However, OST clients frequently have other problems that are not well served by OST alone such as high OST drop-out and continued polysubstance use during OST. The latter can include "topping up" with opioids, using substances that are dangerous when combined with OST (e.g., sedatives), and risky administration routes (e.g., injection). We have recently shown that personality traits that predict risk for mental health/behavioral problems also predict risky forms and routes of substance use in OST clients. We will use our expertise in brief cognitive-behavioral interventions and clinical research methods to test the feasibility of personality-targeted substance use interventions in OST clients. We are currently using our existing personality model along with interviews already collected from OST clients and service providers to adapt our personality-targeted interventions. For the proposed grant, in collaboration with our knowledge user partners, we will aim to try 4 personality-targeted interventions with clients across 4 OST clinics, evaluate feasibility, and provide a first test of their impacts on clients' polysubstance use and OST retention. We will examine feasibility from the perspectives of clients, therapists, and clinic directors to see if the personality targeted approach should be pursued further in this population. 

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Advance Consent for participation in Acute Stroke Trials (ACTION): protocol for a feasibility study.

Developing a Model of Advance Consent for Participation in Acute Stroke Trials.

Inhibited personality traits, internalizing symptoms, and drinking to cope during the COVID-19 pandemic among emerging adults.